Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China

MLA

Qing, Wen, et al. “Real-World Evidence of ABVD-like Regimens Compared with ABVD in Classical Hodgkin Lymphoma: A 10-Year Study from China.” Journal of Cancer Research and Clinical Oncology, Aug. 2022. EBSCOhost, https://doi.org/10.1007/s00432-022-04321-6.

APA

Qing, W., Jingjing, G., Yaxin, L., Yue, Z., Xiaoshuang, K., Wenhua, W., Huting, H., Zeyuan, W., Siyu, Q., Mengjie, D., Meng, D., Linan, Z., Mingzhi, Z., Xudong, Z., & Qingjiang, C. (2022). Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-022-04321-6

Chicago

Qing, Wen, Ge Jingjing, Lei Yaxin, Zhang Yue, Kong Xiaoshuang, Wang Wenhua, Hou Huting, et al. 2022. “Real-World Evidence of ABVD-like Regimens Compared with ABVD in Classical Hodgkin Lymphoma: A 10-Year Study from China.” Journal of Cancer Research and Clinical Oncology, August. doi:10.1007/s00432-022-04321-6.